NKTR
Nektar Therapeutics
60.40$
+5.9%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +15.0% | -28.3% | +86.0% | +287.8% | -90.4% | +33.4% | -33.4% | -9.7% | -2.1% | +9.2% | -43.9% | |
| – | +19.5% | -11.4% | +1.1% | -20.1% | -12.4% | -8.9% | +27.8% | -13.1% | +69.4% | -16.3% | -100.0% | |
| – | +14.2% | -31.2% | +105.0% | +321.7% | -92.0% | +43.1% | -42.3% | -8.6% | -24.1% | +26.7% | -18.5% | |
| – | +23.7% | +11.5% | +31.7% | +48.8% | +8.8% | -6.0% | -2.1% | -45.5% | -47.7% | +5.9% | -3.0% | |
| – | +5.7% | +2.3% | +18.3% | +55.5% | +21.2% | +6.0% | +17.3% | -24.8% | -16.2% | -0.9% | -10.5% | |
| – | +19.8% | +9.7% | +29.3% | +49.9% | +10.9% | -3.7% | +1.9% | -40.6% | -38.5% | -9.4% | +7.6% | |
| – | – | – | – | – | -164.0% | – | – | – | – | – | – | |
| – | +0.4% | +8.4% | -2.9% | +4.5% | +8.4% | -19.9% | +27.5% | -38.9% | -12.4% | +11.0% | -6.9% | |
| – | – | – | – | – | -164.5% | – | – | – | – | – | – | |
| – | – | +73.1% | -29.7% | +129.2% | -56.6% | -19.6% | +13.0% | +477.2% | -106.2% | – | – | |
| – | – | – | – | – | -164.7% | – | – | – | – | – | – | |
| – | – | – | – | – | -152.1% | – | – | – | – | – | – |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.